Literature DB >> 18854946

Cystoid macular edema in polypoidal choroidal vasculopathy viewed by a scanning laser ophthalmoscope: CME in PCV viewed by SLO.

Motoshi Yamamoto1, Akitaka Tsujikawa, Shiho Mizukami, Norimi Miyoshi, Nagahisa Yoshimura.   

Abstract

Visual prognosis for polypoidal choroidal vasculopathy (PCV) is reported to be relatively good. However, some eyes in the end-stage of PCV show cystoid macular edema (CME) with severe loss of vision. We examined two eyes with CME in the end-stage of PCV. The fundus of each of these eyes was examined noninvasively with a new commercially available scanning laser ophthalmoscope (SLO) in the retro-mode with an infrared laser. In the retro-mode, scattered light that passed the aperture deviated laterally, giving a shadow to the silhouetted cystoid spaces, enabled visualisation of the CME. In each eye, although no cystoid spaces were detected on fundus photographs, monochromatic images obtained with an SLO in the retro-mode showed numerous cystoid spaces on the disciform scar. SLO in the retro-mode can show each cystoid space located in any layer of the retina, and allows us to detect the extent of the CME.

Entities:  

Mesh:

Year:  2008        PMID: 18854946     DOI: 10.1007/s10792-008-9274-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  5 in total

1.  Three-dimensional imaging of cystoid macular edema in retinal vein occlusion.

Authors:  Noritatsu Yamaike; Akitaka Tsujikawa; Masafumi Ota; Atsushi Sakamoto; Yuriko Kotera; Mihori Kita; Kazuaki Miyamoto; Nagahisa Yoshimura; Masanori Hangai
Journal:  Ophthalmology       Date:  2007-08-02       Impact factor: 12.079

2.  Examination of patients with cystoid macular edema using a scanning laser ophthalmoscope with infrared light.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Am J Ophthalmol       Date:  1998-05       Impact factor: 5.258

3.  Infrared imaging of cystoid macular edema.

Authors:  A Remky; E Beausencourt; M E Hartnett; C L Trempe; O Arend; A E Elsner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-11       Impact factor: 3.117

4.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

5.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

  5 in total
  5 in total

1.  Comparing different imaging modalities in harada disease: a case report.

Authors:  Nan-Kai Wang; Chai Lin Chou; Stephen H Tsang
Journal:  Retin Cases Brief Rep       Date:  2010

2.  Confocal scanning laser ophthalmoscope in the retromode imaging modality in exudative age-related macular degeneration.

Authors:  Elisabetta Pilotto; Patrik Sportiello; Ernesto Alemany-Rubio; Stela Vujosevic; Sara Segalina; Iva Fregona; Edoardo Midena
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-29       Impact factor: 3.117

3.  Retromode imaging: Review and perspectives.

Authors:  Won June Lee; Byung Ro Lee; Yong Un Shin
Journal:  Saudi J Ophthalmol       Date:  2014-02-20

4.  The noninvasive retro-mode imaging modality of confocal scanning laser ophthalmoscopy in polypoidal choroidal vasculopathy: a preliminary application.

Authors:  Renpan Zeng; Xiongze Zhang; Yu Su; Meng Li; Kunfang Wu; Feng Wen
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

5.  Retro-mode imaging and fundus autofluorescence with scanning laser ophthalmoscope of retinal dystrophies.

Authors:  Battaglia Parodi Maurizio; Iacono Pierluigi; Kontadakis Stelios; Vergallo Stefano; Cascavilla Marialucia; Zucchiatti Ilaria; Bandello Francesco
Journal:  BMC Ophthalmol       Date:  2012-05-15       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.